发明名称 Method of treating osteoarthritis with an antibody to NGF
摘要 Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritis is prevented, ameliorated or improved.
申请公布号 US9353176(B2) 申请公布日期 2016.05.31
申请号 US201314038349 申请日期 2013.09.26
申请人 Regeneron Pharmaceuticals, Inc. 发明人 MacDonald Lynn;Torres Richard;Morra Marc R.;Martin Joel H.;Reinhardt Joel C.;Tiseo Paul
分类号 A61K39/395;C07K16/22;A61K45/06;A61K39/00 主分类号 A61K39/395
代理机构 代理人 Mallon Veronica;Bozicevic Karl
主权项 1. A method for ameliorating, improving or inhibiting osteoarthritic pain in a human subject in need thereof, comprising: administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritic pain is inhibited, ameliorated or improved, wherein the antibody or antigen-binding fragment thereof comprises: the three heavy chain CDRs (HCDR1, HCDR2 and HCDR3) contained within any one of the heavy chain variable region (HCVR) sequences encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 3, 19 and 23; and three light chain CDRs (LCDR1, LCDR2 and LCDR3) contained within any one of the light chain variable region (LCVR) sequences encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 11, 21 and 25.
地址 Tarrytown NY US